1. Home
  2. OGEN vs FTEL Comparison

OGEN vs FTEL Comparison

Compare OGEN & FTEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oragenics Inc.

OGEN

Oragenics Inc.

HOLD

Current Price

$0.74

Market Cap

3.6M

Sector

Health Care

ML Signal

HOLD

Logo Fitell Corporation

FTEL

Fitell Corporation

HOLD

Current Price

$2.14

Market Cap

3.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
OGEN
FTEL
Founded
1996
2007
Country
United States
Australia
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6M
3.7M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
OGEN
FTEL
Price
$0.74
$2.14
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
911.2K
260.3K
Earning Date
03-13-2026
11-17-2025
Dividend Yield
N/A
68.38%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$5,200,138.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
16.42
52 Week Low
$0.74
$2.22
52 Week High
$18.90
$1,314.56

Technical Indicators

Market Signals
Indicator
OGEN
FTEL
Relative Strength Index (RSI) 35.71 46.62
Support Level $0.77 $2.22
Resistance Level $0.84 $3.85
Average True Range (ATR) 0.07 0.36
MACD -0.01 -0.16
Stochastic Oscillator 4.00 2.33

Price Performance

Historical Comparison
OGEN
FTEL

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.

About FTEL Fitell Corporation

Fitell Corp conducts its primary operations of selling gym and fitness equipment in Australia through its indirectly held wholly owned subsidiary, serving personal training studios and commercial gyms. Its product coverage includes four proprietary brands: Muscle Motion for strength-training equipment, Rapid Motion with a focus on commercial items, FleetX for cardio equipment, and Harison for cardio, strength, recovery, and conditioning products. The Company operates in one segment, trading gym equipment, and also provides licensing services and gym equipment to overseas gym studios. Majority of its business is conducted in Australia via its e-commerce platform and third-party sites, with maximum revenue earned from retail.

Share on Social Networks: